NCT02574650 - Early Feasibility of the Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) Also Known as TriAlign™. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2019

Conditions

Chronic Symptomatic Functional Tricuspid RegurgitationTricuspid Valve InsufficiencyHeart Valve Disease

Interventions

DEVICE

Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS)

Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) delivered by a percutaneous transcatheter procedure.

Trial Locations (11)

10032

RECRUITING

Columbia University Medical Center / New York-Presbyterian Hospital, New York

20010

RECRUITING

MedStar Washington Hospital Center, Washington D.C.

22908

RECRUITING

University of Virginia, Charlottesville

30309

RECRUITING

Piedmont Healthcare, Atlanta

33484

RECRUITING

Delray Medical Center, Delray Beach

55407

RECRUITING

Minneapolis Heart Institute Foundation, Minneapolis

60611

RECRUITING

Northwestern University / Bluhm Cardiovascular Institute, Chicago

77030

RECRUITING

Houston Methodist, Houston

90048

RECRUITING

Cedars-Sinai Medical Center, Los Angeles

94115

RECRUITING

Kaiser Permanente, San Francisco

98122

RECRUITING

Swedish Medical Center, Seattle